Skip to main content
Top
Published in: Neurological Sciences 3/2017

01-03-2017 | History of Neurology

Rediagnosing one of Smith’s patients (John McCann) with “neuromas tumours” (1849)

Authors: Martino Ruggieri, Andrea D. Praticò, Rosario Caltabiano, Agata Polizzi

Published in: Neurological Sciences | Issue 3/2017

Login to get access

Abstract

In 1849, the Irish Professor of Surgery, Sir Robert William Smith, by publishing his “Treatise on the Pathology, Diagnosis and Treatment of Neuroma”, collected six previous examples of “general development of neuromatous tumours” and reported three further cases (two personal and one referred) of what is nowadays known as neurofibromatosis. Among these latter cases, there was a 35-year-old cattle-driver, John McCann, who was first admitted at hospital in 1840 because of a large tumour on the right side of his neck thought to be malignant (and a second tumour sublingually) but not operated. McCann was readmitted in 1843 (“in an emaciated state”), because of an immense tumour in his thigh dying few months later “with hepatic symptoms”. Smith’s post-mortem examination revealed dozens of smaller additional tumours. Based on application of modern diagnostic criteria (to McCann’s portrait at second referral) and on pathological grounds (reconsideration of the histopathological report of McCann’s neuroma of the thigh), we tentatively hypothesise that this patient could be the earliest (illustrated) example of either: (1) a malignant peripheral nerve sheath tumour (MPNST); (2) neurofibromatosis type 2 (NF2); or (3) schwannomatosis (SWNTS). The progressively enlarging masses, the emaciated state and the later death are in favour of a MPNST (against is the lack of malignant appearance at histopathology); the clinical (and gross pathological) appearance of the tumours as large, rounded, encapsulated, eccentric lesions deflecting the parent nerve over the surface of the tumour is typical of schwannomas (thus, in favour of NF2 or SWTNS). Whatever diagnosis we could consider these tumours could be secondary to a (local) mosaic loss of heterozygosity and ultimately represent type 2 segmental manifestations superimposed on an ordinary autosomal dominant trait (i.e., NF1, NF2 or SWTNS).
Literature
1.
go back to reference Ruggieri M, Praticò AD, Serra A, Maiolino L, Cocuzza S, Caltabiano R, Polizzi A (2016) Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers beyond the eponyms. Child Nerv Syst. doi:10.1007/s00381-016-3226-8 Ruggieri M, Praticò AD, Serra A, Maiolino L, Cocuzza S, Caltabiano R, Polizzi A (2016) Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers beyond the eponyms. Child Nerv Syst. doi:10.​1007/​s00381-016-3226-8
2.
go back to reference Smith RW (1849) A treatise on the pathology, diagnosis and treatment of neuromas. Hodges & Smith, Dublin Smith RW (1849) A treatise on the pathology, diagnosis and treatment of neuromas. Hodges & Smith, Dublin
3.
go back to reference Fulton JF, Robert W (1929) Smith’s description of generalised neurofibromatosis. N Engl J Med 200:1315–1317CrossRef Fulton JF, Robert W (1929) Smith’s description of generalised neurofibromatosis. N Engl J Med 200:1315–1317CrossRef
4.
go back to reference Huson SM, Hughes RAC (1994) The neurofibromatoses: pathogenetic and clinical overview. Chapman & Hall, London Huson SM, Hughes RAC (1994) The neurofibromatoses: pathogenetic and clinical overview. Chapman & Hall, London
5.
go back to reference Von Recklinghausen FD (1882) Uber ide multiplen Fibrome der Haut und ihre beziehung zu den multiplen Neuromen. Hirschwald, Berlin 1882:3–18 Von Recklinghausen FD (1882) Uber ide multiplen Fibrome der Haut und ihre beziehung zu den multiplen Neuromen. Hirschwald, Berlin 1882:3–18
6.
go back to reference Lyons JB, Staunton H (1992) Neurofibromatosis: why not Smith’s disease? J Hist Neurosci 1:65–73CrossRefPubMed Lyons JB, Staunton H (1992) Neurofibromatosis: why not Smith’s disease? J Hist Neurosci 1:65–73CrossRefPubMed
7.
go back to reference Smith RW (1847) A treatise on fractures in the vicinity of joints and on certain forms of accidental and congenital dislocations. Hodges and Smith, Dublin, pp 6–164 Smith RW (1847) A treatise on fractures in the vicinity of joints and on certain forms of accidental and congenital dislocations. Hodges and Smith, Dublin, pp 6–164
8.
go back to reference Shah HM, Chung KC (2008) Robert William Smith: his life and his contributions to Medicine. J Hand Surg 33A:948–951CrossRef Shah HM, Chung KC (2008) Robert William Smith: his life and his contributions to Medicine. J Hand Surg 33A:948–951CrossRef
11.
go back to reference Ruggieri M, Huson SM (1999) The neurofibromatoses. An overview. Neurol Sci 20:89–108CrossRef Ruggieri M, Huson SM (1999) The neurofibromatoses. An overview. Neurol Sci 20:89–108CrossRef
12.
go back to reference Kleihues P, Cavenee WK (2000) Pathology and genetics. Tumours of the nervous system. IARC Press, Lyon Kleihues P, Cavenee WK (2000) Pathology and genetics. Tumours of the nervous system. IARC Press, Lyon
13.
go back to reference Burger PC, Scheithauer BW, Vogel FS (2002) Surgical pathology of the nervous system and its coverings, 4th edn. Churchill Livingstone, London, p 595 Burger PC, Scheithauer BW, Vogel FS (2002) Surgical pathology of the nervous system and its coverings, 4th edn. Churchill Livingstone, London, p 595
14.
go back to reference Enzinger & Weiss’s (2008) Soft tissue tumors, 5th edn. Mosby Elsevier, Philadelphia, p 853 Enzinger & Weiss’s (2008) Soft tissue tumors, 5th edn. Mosby Elsevier, Philadelphia, p 853
16.
go back to reference Ruggieri M, Praticò AD, Evans DG (2015) Diagnosis, management and new therapeutic options in childhood neurofibromatosis type 2 (NF2) and related disorders. Semin Pediatr Neurol 22:240–258CrossRefPubMed Ruggieri M, Praticò AD, Evans DG (2015) Diagnosis, management and new therapeutic options in childhood neurofibromatosis type 2 (NF2) and related disorders. Semin Pediatr Neurol 22:240–258CrossRefPubMed
17.
go back to reference Baser ME, Friedman JM, Evans DG (2006) Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology 66:730–732CrossRefPubMed Baser ME, Friedman JM, Evans DG (2006) Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology 66:730–732CrossRefPubMed
18.
go back to reference Smith MJ, Kulkarni A, Rustad C et al (2012) Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. Am J Med Genet A 158A:215–219CrossRefPubMed Smith MJ, Kulkarni A, Rustad C et al (2012) Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis. Am J Med Genet A 158A:215–219CrossRefPubMed
19.
go back to reference Plotkin SR, Blakeley JO, Evans DG et al (2013) Update from the 2011 international schwannomatosis workshop: from genetics to diagnostic criteria. Am J Med Genet A 161A:405–416CrossRefPubMed Plotkin SR, Blakeley JO, Evans DG et al (2013) Update from the 2011 international schwannomatosis workshop: from genetics to diagnostic criteria. Am J Med Genet A 161A:405–416CrossRefPubMed
20.
go back to reference Smith MJ, Bowers NL, Bulman M et al (2017) Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis. Neurology 88:87–92CrossRefPubMed Smith MJ, Bowers NL, Bulman M et al (2017) Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis. Neurology 88:87–92CrossRefPubMed
21.
go back to reference Ruggieri M, Iannetti P, Polizzi A et al (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 in childhood: a study of 24 patients. Neuropediatrics 36:21–34CrossRefPubMed Ruggieri M, Iannetti P, Polizzi A et al (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 in childhood: a study of 24 patients. Neuropediatrics 36:21–34CrossRefPubMed
22.
go back to reference Ruggieri M, Gabriele AL, Polizzi A et al (2013) Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 14:89–98CrossRefPubMed Ruggieri M, Gabriele AL, Polizzi A et al (2013) Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 14:89–98CrossRefPubMed
23.
go back to reference Ahn MS, Jackler RK, Lustig LR (1996) The early history of the neurofibromatoses. Evolution of the concept of neurofibromatosis type 2. Arch Otolaryngol Head Neck 122:1240–1249CrossRef Ahn MS, Jackler RK, Lustig LR (1996) The early history of the neurofibromatoses. Evolution of the concept of neurofibromatosis type 2. Arch Otolaryngol Head Neck 122:1240–1249CrossRef
24.
go back to reference Sonig A, Gandhl V, Nanda A (2014) From the cell of Schwann to Schwannoma: a century’s fruition. World Neurosurg 82:906–911CrossRefPubMed Sonig A, Gandhl V, Nanda A (2014) From the cell of Schwann to Schwannoma: a century’s fruition. World Neurosurg 82:906–911CrossRefPubMed
25.
go back to reference Schieppati A, Enter JI, Daina E, Apeina A (2008) Why rare diseases are an important medical and social issue. Lancet 371:2039–2041CrossRefPubMed Schieppati A, Enter JI, Daina E, Apeina A (2008) Why rare diseases are an important medical and social issue. Lancet 371:2039–2041CrossRefPubMed
26.
go back to reference Happle R (1996) Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 66:241–242CrossRefPubMed Happle R (1996) Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 66:241–242CrossRefPubMed
27.
go back to reference Happle R (1997) A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 133:1505–1509CrossRefPubMed Happle R (1997) A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 133:1505–1509CrossRefPubMed
28.
go back to reference Happle R (2014) Two major categories of mosaicism. In: Happle R (ed) Mosaicism in human skin. Understanding nevi, nevoid skin disorders, and cutaneous neoplasia. Springer, Berlin, pp 13–37 Happle R (2014) Two major categories of mosaicism. In: Happle R (ed) Mosaicism in human skin. Understanding nevi, nevoid skin disorders, and cutaneous neoplasia. Springer, Berlin, pp 13–37
29.
go back to reference Ruggieri M, Praticò AD (2015) Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 22:207–233CrossRefPubMed Ruggieri M, Praticò AD (2015) Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 22:207–233CrossRefPubMed
30.
go back to reference Ruggieri M, Polizzi A (2000) Segmental neurofibromatosis. J Neurosurg 95:530–532 Ruggieri M, Polizzi A (2000) Segmental neurofibromatosis. J Neurosurg 95:530–532
31.
go back to reference Ruggieri M (2001) Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2)—no longer neurofibromatosis type 5 (2001). Am J Med Genet 101:178–180CrossRefPubMed Ruggieri M (2001) Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2)—no longer neurofibromatosis type 5 (2001). Am J Med Genet 101:178–180CrossRefPubMed
32.
go back to reference Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433–1443CrossRefPubMed Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433–1443CrossRefPubMed
33.
go back to reference Ruggieri M, Praticò AD, Serra A et al (2016) Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital 36:345–367PubMedPubMedCentral Ruggieri M, Praticò AD, Serra A et al (2016) Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital 36:345–367PubMedPubMedCentral
34.
go back to reference Ruggieri M, Polizzi A (2003) From aldrovandi’s homuncio (1592) to buffon’s girl (1749) and the wart man of tilesisus (1793): antique illustrations of mosaicism in neurofibromatosis? J Med Genet 40:227–232CrossRefPubMedPubMedCentral Ruggieri M, Polizzi A (2003) From aldrovandi’s homuncio (1592) to buffon’s girl (1749) and the wart man of tilesisus (1793): antique illustrations of mosaicism in neurofibromatosis? J Med Genet 40:227–232CrossRefPubMedPubMedCentral
Metadata
Title
Rediagnosing one of Smith’s patients (John McCann) with “neuromas tumours” (1849)
Authors
Martino Ruggieri
Andrea D. Praticò
Rosario Caltabiano
Agata Polizzi
Publication date
01-03-2017
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 3/2017
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-016-2797-1

Other articles of this Issue 3/2017

Neurological Sciences 3/2017 Go to the issue